AAAAAA

   
Results: 1-18 |
Results: 18

Authors: KOVAL AP BLAKESLEY VA ROBERTS CT ZICK Y LEROITH D
Citation: Ap. Koval et al., INTERACTION IN-VITRO OF THE PRODUCT OF THE C-CRK-II PROTOONCOGENE WITH THE INSULIN-LIKE-GROWTH-FACTOR-I RECEPTOR, Biochemical journal, 330, 1998, pp. 923-932

Authors: OKUBO Y BLAKESLEY VA STANNARD B GUTKIND S LEROITH D
Citation: Y. Okubo et al., INSULIN-LIKE GROWTH-FACTOR-I INHIBITS THE STRESS-ACTIVATED PROTEIN KINASE C-JUN N-TERMINAL KINASE/, The Journal of biological chemistry, 273(40), 1998, pp. 25961-25966

Authors: BLAKESLEY VA KOVAL AP STANNARD BS SCRIMGEOUR A LEROITH D
Citation: Va. Blakesley et al., REPLACEMENT OF TYROSINE-1251 IN THE CARBOXYL-TERMINUS OF THE INSULIN-LIKE GROWTH-FACTOR-I RECEPTOR DISRUPTS THE ACTIN CYTOSKELETON AND INHIBITS PROLIFERATION AND ANCHORAGE-INDEPENDENT GROWTH, The Journal of biological chemistry, 273(29), 1998, pp. 18411-18422

Authors: BUTLER AA BLAKESLEY VA TSOKOS M POULIKI V WOOD TL LEROITH D
Citation: Aa. Butler et al., STIMULATION OF TUMOR-GROWTH BY RECOMBINANT HUMAN INSULIN-LIKE GROWTH-FACTOR-I (IGF-I) IS DEPENDENT ON THE DOSE AND THE LEVEL OF IGF-I RECEPTOR EXPRESSION, Cancer research, 58(14), 1998, pp. 3021-3027

Authors: LEROITH D PARRIZAS M BLAKESLEY VA
Citation: D. Leroith et al., THE INSULIN-LIKE GROWTH-FACTOR-I RECEPTOR AND APOPTOSIS - IMPLICATIONS FOR THE AGING PROGRESS, ENDOCRINE, 7(1), 1997, pp. 103-105

Authors: LEROITH D BLAKESLEY VA
Citation: D. Leroith et Va. Blakesley, THE YIN AND THE YANG OF THE IGF SYSTEM - IMMUNOLOGICAL MANIFESTATIONSOF GH RESISTANCE, European journal of endocrinology, 136(1), 1997, pp. 33-34

Authors: BLAKESLEY VA STANNARD BS KALEBIC T HELMAN LJ LEROITH D
Citation: Va. Blakesley et al., ROLE OF THE IGF-I RECEPTOR IN MUTAGENESIS AND TUMOR PROMOTION, Journal of Endocrinology, 152(3), 1997, pp. 339-344

Authors: LIU JL BLAKESLEY VA GUTKIND JS LEROITH D
Citation: Jl. Liu et al., THE CONSTITUTIVELY ACTIVE MUTANT G(ALPHA-13) TRANSFORMS MOUSE FIBROBLAST CELLS DEFICIENT IN INSULIN-LIKE GROWTH-FACTOR-I RECEPTOR, The Journal of biological chemistry, 272(47), 1997, pp. 29438-29441

Authors: BUTLER AA BLAKESLEY VA KOVAL A DEJONG R GROFFEN J LEROITH D
Citation: Aa. Butler et al., IN-VIVO REGULATION OF CRKII AND CRKL PROTOONCOGENES IN THE UTERUS BY INSULIN-LIKE GROWTH-FACTOR-I - DIFFERENTIAL-EFFECTS ON TYROSINE PHOSPHORYLATION AND ASSOCIATION WITH PAXILLIN, The Journal of biological chemistry, 272(44), 1997, pp. 27660-27664

Authors: BLAKESLEY VA BEITNERJOHNSON D VANBROCKLYN JR RANI S SHENORR Z STANNARD BS SPIEGEL S LEROITH D
Citation: Va. Blakesley et al., SPHINGOSINE 1-PHOSPHATE STIMULATES TYROSINE PHOSPHORYLATION OF CRK, The Journal of biological chemistry, 272(26), 1997, pp. 16211-16215

Authors: ESPOSITO DL BLAKESLEY VA KOVAL AP SCRIMGEOUR AG LEROITH D
Citation: Dl. Esposito et al., TYROSINE RESIDUES IN THE C-TERMINAL DOMAIN OF THE INSULIN-LIKE GROWTH-FACTOR-I RECEPTOR MEDIATE MITOGENIC AND TUMORIGENIC SIGNALS, Endocrinology, 138(7), 1997, pp. 2979-2988

Authors: SCRIMGEOUR AG BLAKESLEY VA STANNARD BS LEROTH D
Citation: Ag. Scrimgeour et al., MITOGEN-ACTIVATED PROTEIN-KINASE AND PHOSPHATIDYLINOSITOL 3-KINASE PATHWAYS ARE NOT SUFFICIENT FOR INSULIN-LIKE-GROWTH-FACTOR I-INDUCED MITOGENESIS AND TUMORIGENESIS, Endocrinology, 138(6), 1997, pp. 2552-2558

Authors: NAJJAR SM BLAKESLEY VA CALZI SL KATO H LEROITH D CHOICE CV
Citation: Sm. Najjar et al., DIFFERENTIAL PHOSPHORYLATION OF PP120 BY INSULIN AND INSULIN-LIKE GROWTH-FACTOR-I RECEPTORS - ROLE FOR THE C-TERMINAL DOMAIN OF THE BETA-SUBUNIT, Biochemistry, 36(22), 1997, pp. 6827-6834

Authors: PARRIZAS M BLAKESLEY VA BEITNERJOHNSON D LEROITH D
Citation: M. Parrizas et al., THE PROTOONCOGENE CRK-II ENHANCES APOPTOSIS BY A RAS-DEPENDENT, RAF-1MAP KINASE-INDEPENDENT PATHWAY/, Biochemical and biophysical research communications, 234(3), 1997, pp. 616-620

Authors: BEITNERJOHNSON D BLAKESLEY VA SHENORR Z JIMENEZ M STANNARD B WANG LM PIERCE J LEROITH D
Citation: D. Beitnerjohnson et al., THE PROTOONCOGENE PRODUCT C-CRK ASSOCIATES WITH INSULIN-RECEPTOR SUBSTRATE-1 AND 4PS - MODULATION BY INSULIN GROWTH-FACTOR-I (IGF) AND ENHANCED IGF-1 SIGNALING, The Journal of biological chemistry, 271(16), 1996, pp. 9287-9290

Authors: BLAKESLEY VA KALEBIC T HELMAN LJ STANNARD B FARIA TN ROBERTS CT LEROITH D
Citation: Va. Blakesley et al., TUMORIGENIC AND MITOGENIC CAPACITIES ARE REDUCED IN TRANSFECTED FIBROBLASTS EXPRESSING MUTANT INSULIN-LIKE GROWTH-FACTOR (IGF)-I RECEPTORS - THE ROLE OF TYROSINE RESIDUE-1250, RESIDUE-1251, AND RESIDUE-1316 INTHE CARBOXY-TERMINUS OF THE IGF-I RECEPTOR, Endocrinology, 137(2), 1996, pp. 410-417

Authors: BLAKESLEY VA KATO H ROBERTS CT LEROITH D
Citation: Va. Blakesley et al., MUTATION OF A CONSERVED AMINO-ACID RESIDUE (TRYPTOPHAN-1173) IN THE TYROSINE KINASE DOMAIN OF THE IGF-I RECEPTOR ABOLISHES AUTOPHOSPHORYLATION BUT DOES NOT ELIMINATE BIOLOGIC FUNCTION, The Journal of biological chemistry, 270(6), 1995, pp. 2764-2769

Authors: FARIA TN BLAKESLEY VA KATO H STANNARD B LEROITH D ROBERTS CT
Citation: Tn. Faria et al., ROLE OF THE CARBOXYL-TERMINAL DOMAINS OF THE INSULIN AND INSULIN-LIKEGROWTH-FACTOR-I RECEPTORS IN RECEPTOR FUNCTION, The Journal of biological chemistry, 269(19), 1994, pp. 13922-13928
Risultati: 1-18 |